GENERIUM is a full—cycle research and production company – a leader in the orphan segment of the Russian pharmaceutical market.
The company has its own R&D park capable of developing any biotechnological drug from the creation of a molecule to the start of industrial production. Scientific research on individual drugs is conducted jointly with leading biotech companies and scientific institutes from around the world.
The company's production site is organized in strict accordance with international GMP standards and is capable of producing a unique assortment of biotechnological medicines and biomedical cell products.
There is no newsletter category found.
Наш сайт использует файлы cookie для хранения данных.
Продолжая использовать сайт, вы даёте согласие на работу с этими файлами.